Peth Yoeung by First Womentech Asia Co., Ltd. is a Cambodia’s largest cloud-based Hospital Management Software Platform created to advance our healthcare ecosystem in Cambodia and ASEAN nations through securing medical records, patient data and smoothening hospital operating processes and is also integrated with a premier healthcare marketplace to help improving the pathway to access to healthcare of people anywhere, anytime conveniently. Peth Yoeung has set strong footprint in Cambodia and is recognized by the Ministry of Health of Cambodia. Peth Yoeung won national competition as the social start-up business to join the international competition in Geneva, Switzerland 2019 (distance) and award from the Ministry of Post and Telecommunications last March 2019.

It has been deployed for nearly 200 public and private hospitals and clinics—covering 15 provinces and Phnom Penh, Cambodia. Nearly 10k active users of combined medical doctors, nurses, pharmacists, lab technicians, health professionals and hospital related administrative staffs signed up with Peth Yoeung. We have been making positive impact on the life and healthcare of nearly 2 million Cambodian population and have made millions of medical records available and accessible online anywhere, anytime for better healthcare and treatment.

AirGuard Industries (HK) Limited is a start-up company that offers an Interior Air Quality solution: the testing of interior air, its constant cleansing by an award-winning, all-natural liquid formulation via active air purification technology, and the ongoing monitoring of air quality.
Unlike other products in the air sanitation market that contain noxious chemicals or use ionization, both of which are harmful to health (especially for young children), our AirGuard™ solution is plant-based, non-toxic and entirely bio-degradable. It works by moving through the air by way of active air technology, and as it moves in vaporized form it disables and inactivates Volatile Organic Compounds (VOCs), bacteria, molds, viruses and pathogens, including SARS-CoV-2 (the COVID-19 virus).
Our service is a huge competitive differentiator for any institution – be it a food producer, school, hotel, bank, business office, entertainment venue, etc. – that believes clean internal air is indispensable in ensuring product safety and the health of its employees and clients. Our green credentials further serve to enhance a company’s commitment to Environment, Social and Governance (ESG) criteria as well as to the United Nations’ Sustainable Development Goals, though it should be added that our technology can equally be applied for home use.

Cartosense’s vision is to make targeted surgery more precise and accessible. Cartosense has developed the world’s first mobile surgical navigation product – reducing a 200kg capital equipment product constrained to the OT, into a mobile unit that fits into a briefcase. Surgical navigation is technology that tracks the surgeon’s instruments while operating on a patient and provides real-time feedback about the current position and trajectory of an instrument with respect to the patient’s MRI/CT images. This makes it almost like a GPS system for the surgeon – only accurate to the millimetre level.

Our breakthrough product is a result of deep expertise in optics, mathematical modelling, computer vision, graphics, and precision engineering. In upcoming improvements to our platform, we are advancing the state of precision surgery through AR/VR and robotics.
Surgical navigation is currently an already established $900M market globally, of which the developed world is a $600M market and the developing world is a high growth $300M market. With increasing penetration in spine and orthopedic surgery and adoption in new applications within ENT, dental surgery, the global surgical navigation market is expected to become a $3B+ market in the next decade. Our technology aims to democratize surgical navigation by accelerating penetration in emerging markets and developing new clinical and business use cases through reverse innovation in the developed markets.

Karmasthal’s aim is to create a one-stop solution to address the elder care market backed by technology. A complete solution where healthcare professionals are assisted by real-time reporting through IoT & predictive technology to create a preventive care solution.

Sparcolife is an Applied Behavioural Sciences Company working on Multimodal Diagnostics and Multisensory Digital Therapeutics to enable the adoption of Integrated Behavioural Care. Vyana Life (Vyli) is our Digital Health platform to detect and address Behavioural & Mental Health issues alongside Fertility Care Treatment using the principles of Integrated Care. Our platform will blend care for medical conditions and related behavioural-mental health factors that affect the patient’s overall health and well-being. Over the next 5 years, we will have served over a million couples across the globe.

SynerSense’s flagship GaitSense product for people with orthopedic impairments and neuromuscular disorders in healthcare and wellness for elder people, sport and industry workplaces safety. GaitSense is body-motion capture wearable multi-sensors and portable gait analysis system, affordable, saves time, revenue maximize. GaitSense provides objective functional activity body-movements (> 50+ key kinematics joints range of motions and spatio-temporal parameters) and body-posture analysis at high accuracy with a proprietary scientific algorithm using a data visualization platform that converts quantitative data into the simplest representation that helps the user to make faster surgical decisions, therapy monitoring, recovery and reduce high-risk of injuries in order to return back to normal daily activities.

Red Arrow Therapeutics’ chemists shape the behavior of proteins by carefully designing polymer-protein conjugates with controlled architecture, composition, size and stimuli responsive chemistry. Our unique approach can then generate prodrug-like proteins with optimal pharmacokinetics, biodistribution and targeted activation at disease sites without compromising the biological action of the proteins. With our novel platform, a broad range of valuable functional attributes will become accessible for therapeutic innovation. As a 1st pipeline, we focused on immunotherapy, where only 20% patients respond to standard immunoncological options, such as immune checkpoint inhibitors (ICIs). Because the immunosuppressive environment of cold tumors is the major reason for immunotherapy failure, Red Arrow Therapeutics has developed protein prodrugs that safely boost antitumor immunity. To this end, we have identified the hit formulation capable of tumor eradication, even in malignancies that are resistant to ICIs, and we will optimize this formulation before large-scale manufacturing, pre-clinical trials and clinical trials. We are convinced that our proprietary platform will attract Japanese investors and pharmaceuticals to jointly develop products, and we aim to achieve IPO with our pipelines toward blockbuster drugs and alliances.

At Craft Health, we are building a platform for 3D printed personalized healthcare. Possible applications include personalized nutrition, decentralized clinical trials, personalized medicine, and 3D printing for orphan drugs.

Since we launched in May 2019, we have:

・Hardware: In-house developed 3D printer specialized for nutraceuticals and pharmaceuticals. Our 3D printer is designed for Good Manufacturing Practice (GMP) and the 3D printing process does not involve heat or ultraviolet (UV) curing, enabling a wide range of active ingredients to be used.
・Software: 3D printing software
・3D printable formulations: A series of proprietary 3D printable formulations for different controlled released profiles (Immediate/sustained/delayed release) that can be combined in a single 3D printed tablet.
・Specialty products: Patent pending 3D printed capsule that converts once daily dosing to once weekly.